Cargando…
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674106/ https://www.ncbi.nlm.nih.gov/pubmed/34905620 http://dx.doi.org/10.1182/bloodadvances.2021006326 |
| _version_ | 1784615575747559424 |
|---|---|
| author | Piñana, José Luis Garcia-Sanz, Ramon Martino, Rodrigo Garcia-Roa, María Martin-Martin, Gabriel Andrés Risco-Gálvez, Irene Tormo, Mar Martinez-Barranco, Pilar Marcos-Corrales, Sara Calabuig, Marisa Conesa, Venancio Teruel, Anabel Ruiz-Pérez, Sara Solano, Carlos Navarro, David Cedillo, Ángel Sureda,, Anna |
| author_facet | Piñana, José Luis Garcia-Sanz, Ramon Martino, Rodrigo Garcia-Roa, María Martin-Martin, Gabriel Andrés Risco-Gálvez, Irene Tormo, Mar Martinez-Barranco, Pilar Marcos-Corrales, Sara Calabuig, Marisa Conesa, Venancio Teruel, Anabel Ruiz-Pérez, Sara Solano, Carlos Navarro, David Cedillo, Ángel Sureda,, Anna |
| author_sort | Piñana, José Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8674106 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86741062021-12-16 Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 Piñana, José Luis Garcia-Sanz, Ramon Martino, Rodrigo Garcia-Roa, María Martin-Martin, Gabriel Andrés Risco-Gálvez, Irene Tormo, Mar Martinez-Barranco, Pilar Marcos-Corrales, Sara Calabuig, Marisa Conesa, Venancio Teruel, Anabel Ruiz-Pérez, Sara Solano, Carlos Navarro, David Cedillo, Ángel Sureda,, Anna Blood Adv Research Letter American Society of Hematology 2022-02-01 /pmc/articles/PMC8674106/ /pubmed/34905620 http://dx.doi.org/10.1182/bloodadvances.2021006326 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Research Letter Piñana, José Luis Garcia-Sanz, Ramon Martino, Rodrigo Garcia-Roa, María Martin-Martin, Gabriel Andrés Risco-Gálvez, Irene Tormo, Mar Martinez-Barranco, Pilar Marcos-Corrales, Sara Calabuig, Marisa Conesa, Venancio Teruel, Anabel Ruiz-Pérez, Sara Solano, Carlos Navarro, David Cedillo, Ángel Sureda,, Anna Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title | Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title_full | Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title_fullStr | Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title_full_unstemmed | Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title_short | Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 |
| title_sort | booster effect after sars-cov-2 vaccination in immunocompromised hematology patients with prior covid-19 |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674106/ https://www.ncbi.nlm.nih.gov/pubmed/34905620 http://dx.doi.org/10.1182/bloodadvances.2021006326 |
| work_keys_str_mv | AT pinanajoseluis boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT garciasanzramon boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT martinorodrigo boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT garciaroamaria boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT martinmartingabrielandres boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT riscogalvezirene boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT tormomar boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT martinezbarrancopilar boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT marcoscorralessara boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT calabuigmarisa boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT conesavenancio boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT teruelanabel boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT ruizperezsara boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT solanocarlos boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT navarrodavid boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT cedilloangel boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 AT suredaanna boostereffectaftersarscov2vaccinationinimmunocompromisedhematologypatientswithpriorcovid19 |